Related Experiment Videos
[Diabetic maculopathy:classification, epidemiology, spontaneous outcome, treatment]
A Gaudric1, P Massin-Korobelnik
1Service d'Ophtalmologie, Hôpital Lariboisière, Paris, France.
Diabete & Metabolisme
|September 1, 1993
Summary
Diabetic macular edema, a leading cause of vision loss, often progresses slowly and may not require urgent treatment. Laser photocoagulation can help manage exudates and stabilize vision in diabetic patients.
Area of Science:
- Ophthalmology
- Diabetology
- Medical Research
Background:
- Diabetic macular edema is a primary cause of visual impairment in diabetes patients.
- Affecting approximately 10% of the diabetic population, it impacts 30% of those with diabetes for over twenty years.
- Macular edema progression is typically slow, with nearly 50% of affected eyes showing no vision change over two years.
Purpose of the Study:
- To review the characteristics and treatment of diabetic macular edema.
- To evaluate the efficacy of laser photocoagulation in managing this condition.
Main Methods:
- Review of existing studies on diabetic macular edema.
- Analysis of treatment outcomes for argon green laser photocoagulation, including extra macular focal photocoagulation and grid photocoagulation.
Main Results:
- Macular edema can spontaneously resolve and may respond to glycemic control.
- Extra macular focal photocoagulation promotes exudate resorption when exudates approach the macula.
- Grid photocoagulation in the perifoveolar area often leads to cystoid macular edema resolution and visual stabilization.
Conclusions:
- Diabetic macular edema does not typically require urgent intervention.
- Laser photocoagulation is an effective treatment for exudative macular edema and cystoid macular edema, primarily achieving visual stabilization.